Andrzej Pilc
#162,493
Most Influential Person Now
Polish pharmacologist, neuroscientist and
Andrzej Pilc's AcademicInfluence.com Rankings
Andrzej Pilcmedical Degrees
Medical
#3297
World Rank
#3762
Historical Rank
Pharmacology
#406
World Rank
#459
Historical Rank
Andrzej Pilcbiology Degrees
Biology
#12956
World Rank
#16467
Historical Rank
Neuroscience
#2221
World Rank
#2282
Historical Rank
Download Badge
Medical Biology
Andrzej Pilc's Degrees
- PhD Pharmacology Jagiellonian University
Why Is Andrzej Pilc Influential?
(Suggest an Edit or Addition)Andrzej Pilc's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Endurance training increases plasma brain-derived neurotrophic factor concentration in young healthy men. (2008) (317)
- Potential anxiolytic‐ and antidepressant‐like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist (2001) (308)
- The effect of physical activity on the brain derived neurotrophic factor: from animal to human studies. (2010) (252)
- Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study. (2003) (229)
- Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs. (2007) (219)
- Upregulation of gamma-aminobutyric acid (GABA) B binding sites in rat frontal cortex: a common action of repeated administration of different classes of antidepressants and electroshock. (1985) (212)
- Mood disorders: regulation by metabotropic glutamate receptors. (2008) (179)
- Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. (2009) (177)
- Antidepressant-like effects of acute and chronic treatment with zinc in forced swim test and olfactory bulbectomy model in rats (2003) (165)
- Zinc and depression. An update. (2005) (164)
- Antidepressant-like properties of zinc in rodent forced swim test (2001) (160)
- Multiple MPEP administrations evoke anxiolytic- and antidepressant-like effects in rats (2002) (152)
- Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. (2008) (143)
- Activation of the mGlu7 receptor elicits antidepressant-like effects in mice (2007) (140)
- Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats (2004) (133)
- The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test (2009) (127)
- Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models (1999) (124)
- Blockade of the metabotropic glutamate receptor subtype 5 (mGluR5) produces antiparkinsonian-like effects in rats (2001) (124)
- Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist (2005) (120)
- Antidepressant- and anxiolytic-like activity of magnesium in mice (2004) (119)
- Enhancement of responsiveness of the central serotonergic system and serotonin-2 receptor density in rat frontal cortex by electroconvulsive treatment. (1981) (117)
- Antidepressant-like activity of zinc: further behavioral and molecular evidence (2008) (116)
- Chronic antidepressants and GABA "B" receptors: a GABA hypothesis of antidepressant drug action. (1984) (113)
- Glutamate-Based Antidepressants: Preclinical Psychopharmacology (2013) (111)
- Serum zinc level in depressed patients during zinc supplementation of imipramine treatment. (2010) (106)
- mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants (2013) (104)
- Zinc exhibits an antidepressant-like effect in the forced swimming test in mice. (2000) (96)
- Group II mGlu receptor agonists inhibit behavioural and electrophysiological effects of DOI in mice (2002) (91)
- Glutamate receptor ligands as anxiolytics. (2001) (91)
- Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABAA signaling (2004) (91)
- The involvement of glutamate in the pathophysiology of depression. (2005) (90)
- The antianxiety-like effects of antagonists of group I and agonists of group II and III metabotropic glutamate receptors after intrahippocampal administration (2001) (90)
- Metabotropic glutamate receptors in the tripartite synapse as a target for new psychotropic drugs (2009) (89)
- GABAergic hypotheses of anxiety and depression: focus on GABA-B receptors. (2005) (88)
- LY354740, a group II metabotropic glutamate receptor agonist with potential antiparkinsonian properties in rats (1998) (86)
- Depression by chronic electroconvulsive treatment of clonidine hypotherma and [3H]clonidine binding to rat cortical membranes. (1982) (84)
- Sipuleucel-T immunotherapy for castration-resistant prostate cancer. A systematic review and meta-analysis (2012) (83)
- The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test (2010) (83)
- NMDA/glutamate mechanism of antidepressant-like action of magnesium in forced swim test in mice (2007) (82)
- Interaction of zinc with antidepressants in the forced swimming test in mice. (2002) (81)
- Functional Selectivity and Antidepressant Activity of Serotonin 1A Receptor Ligands (2015) (78)
- Antidepressant‐like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents (2006) (73)
- Zinc treatment induces cortical brain-derived neurotrophic factor gene expression. (2004) (72)
- Selective activation of metabotropic G-protein-coupled glutamate 7 receptor elicits anxiolytic-like effects in mice by modulating GABAergic neurotransmission (2008) (71)
- Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims. (2013) (70)
- Tumor necrosis factor-α antibodies (infliximab, adalimumab and certolizumab) in Crohn's disease: systematic review and meta-analysis (2013) (67)
- The effectiveness of tofacitinib, a novel Janus kinase inhibitor, in the treatment of rheumatoid arthritis: a systematic review and meta-analysis (2013) (63)
- Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in the rat hippocampus in an animal model of depression. (2001) (62)
- Chronic electroconvulsive treatment enhances the density of [3H]prazosin binding sites in the central nervous system of the rat (1983) (60)
- Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats (2007) (59)
- Neuroprotective effects of metabotropic glutamate receptor group II and III activators against MPP(+)-induced cell death in human neuroblastoma SH-SY5Y cells: The impact of cell differentiation state (2014) (59)
- Antidepressant-like effect of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist in the olfactory bulbectomized rats (2002) (59)
- Activation of alpha-2 adrenergic receptors augments neurotransmitter-stimulated cyclic AMP accumulation in rat brain cerebral cortical slices. (1986) (59)
- A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives (2015) (58)
- Effect of chronic imipramine or electroconvulsive shock on the expression of mGluR1a and mGluR5a immunoreactivity in rat brain hippocampus (2002) (57)
- Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia (2011) (57)
- Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice (2002) (57)
- Attenuation by chronic imipramine treatment of [3H]clonidine binding to cortical membranes and of clonidine-induced hypothermia: the influence of central chemosympathectomy (1982) (56)
- Efficacy of single and repeated administration of ketamine in unipolar and bipolar depression: a meta-analysis of randomized clinical trials (2020) (56)
- On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039 (2010) (56)
- Antibiotic consumption and antimicrobial resistance in Poland; findings and implications (2018) (56)
- Roles of group II metabotropic glutamate receptors in modulation of seizure activity (2000) (56)
- On the role of metabotropic glutamate receptors in the mechanisms of action of antidepressants. (2002) (55)
- Anxiolytic- and antidepressant-like effects of group III metabotropic glutamate agonist (1S,3R,4S)-1-aminocyclopentane-1,3,4-tricarboxylic acid (ACPT-I) in rats. (2002) (55)
- The anxiolytic-like effect of metabotropic glutamate receptor antagonists after intrahippocampal injection in rats. (1997) (54)
- Effects of South African traditional medicine in animal models for depression. (2008) (54)
- An influence of ligands of metabotropic glutamate receptor subtypes on parkinsonian-like symptoms and the striatopallidal pathway in rats (2007) (54)
- Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test. (2012) (54)
- Enhancement of antidepressant-like activity by joint administration of imipramine and magnesium in the forced swim test: Behavioral and pharmacokinetic studies in mice (2005) (54)
- Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems (2010) (53)
- Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats. (2004) (53)
- Effects of acute and chronic treatment with magnesium in the forced swim test in rats. (2005) (51)
- Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment. (2016) (51)
- MTEP, a new selective antagonist of the metabotropic glutamate receptor subtype 5 (mGluR5), produces antiparkinsonian-like effects in rats (2005) (50)
- Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents (2008) (50)
- In vitro and in vivo characterization of MPEP, an allosteric modulator of the metabotropic glutamate receptor subtype 5: Review article (2002) (48)
- Zinc-induced adaptive changes in NMDA/glutamatergic and serotonergic receptors. (2009) (48)
- NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice. (2010) (48)
- Comparative effectiveness of abatacept, apremilast, secukinumab and ustekinumab treatment of psoriatic arthritis: a systematic review and network meta-analysis (2017) (48)
- Activation of the NMDA/glutamate receptor complex antagonizes the NMDA antagonist-induced antidepressant-like effects in the forced swim test. (2007) (48)
- In the Amygdala Anxiolytic Action of mGlu5 Receptors Antagonist MPEP Involves Neuropeptide Y but not GABAA Signaling (2004) (47)
- The Antidepressant-Like Action of Metabotropic Glutamate 7 Receptor Agonist N,N′-Bis(Diphenylmethyl)-1,2-Ethanediamine (AMN082) Is Serotonin-Dependent (2010) (46)
- NMDA antagonists under investigation for the treatment of major depressive disorder (2014) (46)
- Zinc deficiency in rats is associated with up-regulation of hippocampal NMDA receptor (2015) (46)
- Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice (2000) (46)
- Investigational NMDA receptor modulators for depression (2012) (45)
- The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats (2007) (45)
- Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder (2020) (45)
- The role of glutamate receptors in antipsychotic drug action (2000) (44)
- Anxiolytic- but not antidepressant-like activity of Lu AF21934, a novel, selective positive allosteric modulator of the mGlu4 receptor (2013) (44)
- Effect of MPEP treatment on brain-derived neurotrophic factor gene expression. (2006) (42)
- Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats (2014) (41)
- The antipsychotic‐like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents (2013) (41)
- Reduced potency of zinc to interact with NMDA receptors in hippocampal tissue of suicide victims. (2003) (40)
- Involvement of NMDA and AMPA receptors in the antidepressant-like activity of antidepressant drugs in the forced swim test. (2013) (40)
- Alpha up-beta down adrenergic regulation: a possible mechanism of action of antidepressant treatments. (1984) (39)
- Anxiolytic-like effects of group I metabotropic glutamate antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) in rats. (2000) (38)
- Antidepressant treatment influences group I of glutamate metabotropic receptors in slices from hippocampal CA1 region. (1998) (37)
- Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor agonist does not involve GABA(A) signaling. (2004) (36)
- The group III mGlu receptor agonist ACPT-I exerts anxiolytic-like but not antidepressant-like effects, mediated by the serotonergic and GABA-ergic systems (2009) (36)
- Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent (2007) (36)
- Postdecapitation convulsions in the rat measured with an Animex motility meter: relation to central alpha-adrenoceptors. (1982) (36)
- D-serine, a selective glycine/N-methyl-D-aspartate receptor agonist, antagonizes the antidepressant-like effects of magnesium and zinc in mice. (2008) (35)
- Differential effects of NMDA–receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices (2000) (35)
- Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats (2016) (34)
- The correlation between HTA recommendations and reimbursement status of orphan drugs in Europe (2016) (34)
- Zinc deficiency alters responsiveness to antidepressant drugs in mice. (2013) (33)
- Olfactory bulbectomy and amitriptyline treatment influences mGlu receptors expression in the mouse brain hippocampus. (2008) (32)
- The effect of multiple imipramine administration on monoaminergic systems of the rat brain. (1980) (32)
- Anxiolytic-like effect of group III mGlu receptor antagonist is serotonin-dependent (2007) (32)
- Pharmaceutical Regulation in Central and Eastern European Countries: A Current Review (2017) (32)
- Anxiolytic-like effects of group III mGlu receptor ligands in the hippocampus involve GABAA signaling. (2006) (32)
- Effects of GABAB receptor ligands in rodent tests of anxiety-like behavior. (2007) (32)
- Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex (2007) (32)
- Anxiolytic-like activity of zinc in rodent tests. (2011) (32)
- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent (2013) (31)
- Effectiveness of fixed-dose combination therapy in hypertension: systematic review and meta-analysis (2018) (31)
- The Loss of Glutamate-GABA Harmony in Anxiety Disorders (2011) (31)
- The GABAB receptor agonist CGP44532 and the positive modulator GS39783 reverse some behavioural changes related to positive syndromes of psychosis in mice (2011) (31)
- Does histamine interact with cholinergic neurones in its cataleptogenic action in the rat? (1977) (30)
- Efavirenz-Based Regimens in Antiretroviral-Naive HIV-Infected Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (2015) (30)
- Synergistic interaction between α- and β -adrenergic receptors in rat brain slices: Possible site for antidepressant drug action (1985) (29)
- The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling (2013) (29)
- Lack of the antianxiety-like effect of (S)-3,4-DCPG, an mGlu8 receptor agonist, after central administration in rats. (2005) (28)
- Alterations in hippocampal calcium-binding neurons induced by stress models of depression: a preliminary assessment. (2010) (28)
- Lack of NMDA–AMPA interaction in antidepressant-like effect of CGP 37849, an antagonist of NMDA receptor, in the forced swim test (2008) (28)
- Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495 (2016) (27)
- The role of striatal metabotropic glutamate receptors in Parkinson's disease (2002) (27)
- Safety profile of biologic drugs in the therapy of Crohn disease: A systematic review and network meta-analysis. (2016) (26)
- Is the mGlu5 receptor a possible target for new antidepressant drugs? (2013) (26)
- The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies (2014) (26)
- A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats (2013) (26)
- mGlu5-GABAB interplay in animal models of positive, negative and cognitive symptoms of schizophrenia (2015) (25)
- Effect of chronic antidepressant or electroconvulsive shock treatment on mGLuR1a immunoreactivity expression in the rat hippocampus. (1999) (25)
- The role of metabotropic glutamate receptor (mGluR) ligands in parkinsonian muscle rigidity (2000) (25)
- The effect of prolonged imipramine and electroconvulsive shock treatment on calcium/calmodulin-dependent protein kinase II in the hippocampus of rat brain (1999) (24)
- Different pattern of changes in calcium binding proteins immunoreactivity in the medial prefrontal cortex of rats exposed to stress models of depression. (2011) (24)
- Increase in synaptic hippocampal zinc concentration following chronic but not acute zinc treatment in rats (2006) (24)
- Selective group II glutamate metabotropic receptor agonist LY354740 attenuates pentetrazole- and picrotoxin-induced seizures. (1999) (24)
- The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent (2013) (24)
- Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats. (2001) (24)
- Reimbursement of Orphan Drugs in Europe in Relation to the Type of Authorization by the European Medicines Agency and the Decision Making Based on Health Technology Assessment (2018) (24)
- Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortex (2010) (23)
- A role for glutamate in the treatment of anxiety and depression: Focus on group I metabotropic glutamate (mGlu) receptors (2002) (23)
- Involvement of mGlu5 and NMDA receptors in the antidepressant-like effect of acamprosate in the tail suspension test (2012) (23)
- A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action (2015) (23)
- The involvement of monoaminergic neurotransmission in the antidepressant-like action of scopolamine in the tail suspension test (2017) (22)
- Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022 (2016) (22)
- The influence of prolonged antidepressant treatment on the changes in cyclic AMP accumulation induced by excitatory amino acids in rat cerebral cortical slices (1995) (21)
- Selective mGlu5 receptor antagonist MTEP attenuates naloxone-induced morphine withdrawal symptoms. (2004) (20)
- On the mechanism of anti-hyperthermic effects of LY379268 and LY487379, group II mGlu receptors activators, in the stress-induced hyperthermia in singly housed mice (2012) (20)
- Neurochemical and behavioral studies on the 5-HT1A-dependent antipsychotic action of the mGlu4 receptor agonist LSP4-2022 (2017) (20)
- Opiates and specific receptor binding of [3H]clonidine (1980) (20)
- Rapid-eye-movement sleep deprivation inhibits clonidine-induced sedation in rats. (1981) (19)
- Health-Related Quality of Life Impairment and Indirect Cost of Crohn’s Disease: A Self-Report Study in Poland (2016) (19)
- Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet. (2012) (19)
- Neuroprotective effects of mGluR II and III activators against staurosporine- and doxorubicin-induced cellular injury in SH-SY5Y cells: New evidence for a mechanism involving inhibition of AIF translocation (2015) (19)
- Chronic antidepressants and GABA synapses (1984) (18)
- Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats. (2019) (18)
- Influence of histamine on the serotonergic system of rat brain. (1979) (18)
- GABAergic dysfunction in mGlu7 receptor-deficient mice as reflected by decreased levels of glutamic acid decarboxylase 65 and 67kDa and increased reelin proteins in the hippocampus (2010) (18)
- Safety Profile of Biologic Drugs in the Therapy of Ulcerative Colitis: A Systematic Review and Network Meta‐Analysis (2016) (18)
- Glutamate-based anxiolytic ligands in clinical trials (2013) (18)
- Negative Allosteric Modulators of mGlu7 Receptor as Putative Antipsychotic Drugs (2018) (18)
- Pregabalin for the treatment of social anxiety disorder (2015) (17)
- SEPARATION OF ACETYLCHOLINE AND CATECHOLAMINE CONTAINING SYNAPTIC VESICLES FROM BRAIN CORTEX (1977) (17)
- Effects of Magnesium Supplementation on Unipolar Depression: A Placebo-Controlled Study and Review of the Importance of Dosing and Magnesium Status in the Therapeutic Response (2018) (17)
- The influence of 4-methylhistamine, an agonist of histamine H2 receptors on body temperature in rats (1980) (17)
- The Effectiveness of Dimethyl Fumarate Monotherapy in the Treatment of Relapsing-Remitting Multiple Sclerosis: A Systematic Review and Meta-Analysis (2014) (17)
- The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice (2018) (16)
- LY-354740 (Eli Lilly). (2003) (16)
- Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents (2018) (16)
- Expression of group III metabotropic glutamate receptors in the reproductive system of male mice. (2016) (16)
- Glutamate-Based Drug Discovery for Novel Antidepressants (2016) (15)
- An indirect comparison of infliximab versus adalimumab or golimumab for active ulcerative colitis (2016) (15)
- The Trace Kynurenine, Cinnabarinic Acid, Displays Potent Antipsychotic-Like Activity in Mice and Its Levels Are Reduced in the Prefrontal Cortex of Individuals Affected by Schizophrenia. (2020) (15)
- Safety Profile of Biologic Drugs in the Treatment of Inflammatory Bowel Diseases: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials (2016) (15)
- Disease activity, quality of life and indirect costs of psoriatic arthritis in Poland (2016) (14)
- Lu AF21934, a positive allosteric modulator of mGlu4 receptors, reduces the harmaline-induced hyperactivity but not tremor in rats (2014) (14)
- The influence of electroshock on adrenoceptor function in rat brain cerebral cortex: selectivity for the alpha-adrenoceptor site. (1988) (14)
- Antidepressant administration has a differential effect on rat brain alpha 2-adrenoceptor sensitivity to agonists and antagonists. (1986) (14)
- The use of citation indicators to identify and support high-quality research in Poland (2008) (13)
- New evidences for a role of mGluR7 in astrocyte survival: Possible implications for neuroprotection (2018) (13)
- Prolonged administration of antidepressant drugs leads to increased binding of [3H]MPEP to mGlu5 receptors (2014) (13)
- Simultaneous activation of muscarinic and GABAB receptors as a bidirectional target for novel antipsychotics (2019) (12)
- An in vivo procedure for the selective inactivation of rat brain cerebral cortical α-adrenoceptors using N-ethoxycarbonyl-2-ethoxy1,2-dihydroquinoline (EEDQ) (1989) (12)
- Nevirapine-Based Regimens in HIV-Infected Antiretroviral-Naive Patients: Systematic Review and Meta-Analysis of Randomized Controlled Trials (2013) (12)
- Antidepressant-like activity of 8-Br-cAMP, a PKA activator, in the forced swim test (2008) (12)
- Group III mGlu receptor agonist, ACPT-I, attenuates morphine-withdrawal symptoms after peripheral administration in mice (2009) (12)
- (S)-4C3HPG, a mixed group I mGlu receptor antagonist and a group II agonist, administered intrastriatally, counteracts parkinsonian-like muscle rigidity in rats (2001) (12)
- Decreased sensitivity to paroxetine-induced inhibition of peripheral blood mononuclear cell growth in depressed and antidepressant treatment-resistant patients (2016) (12)
- The striatum as a target for anti-rigor effects of an antagonist of mGluR1, but not an agonist of group II metabotropic glutamate receptors (2002) (12)
- Spaced electroconvulsive treatment: effects on responses associated with α2‐ and 5‐HT2–receptors (1983) (12)
- Negligible binding of 3H-clonidine to histamine H2 receptor. (1979) (11)
- Inhibitory actions of mGlu4 receptor ligands on cocaine-, but not nicotine-, induced sensitizing and conditioning locomotor responses in rats. (2014) (11)
- Effectiveness and safety of vedolizumab for treatment of Crohn's disease: a systematic review and meta-analysis (2016) (11)
- Tetracycline-Based System for Controlled Inducible Expression of Group III Metabotropic Glutamate Receptors (2015) (11)
- Over-the-counter medicine and dietary supplement consumption among academic youth in Poland (2016) (10)
- Anxiolytic-like effects of metabotropic glutamate antagonist (RS)-alpha-methylserine-O-phosphate in rats. (1996) (10)
- Ionic Glutamate Modulators in Depression (Zinc, Magnesium) (2010) (10)
- Depression Viewed as a GABA/Glutamate Imbalance in the Central Nervous System (2012) (10)
- Antidepressant treatment influences cyclic AMP accumulation induced by excitatory amino acids in rat brain. (1995) (10)
- Two possible binding sites for 3H-clonidine in the rat cerebral cortex. (1979) (9)
- Cost-Effectiveness Analysis of Crohn’s Disease Treatment with Vedolizumab and Ustekinumab After Failure of Tumor Necrosis Factor-α Antagonist (2018) (9)
- Electroshock-induced increase in [3H]prazosin binding to cortical membranes in reserpinized rats. (1984) (9)
- Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. (2017) (9)
- Direct or indirect action of histamine on dopamine metabolism in the rat striatum? (1977) (9)
- Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents. (2017) (9)
- The usefulness of monitored therapy using Clozapine concentration in the blood serum for determining drug dose in Polish schizophrenic patients. (2016) (9)
- Histidine-induced bizarre behaviour in rats: The possible involvement of central cholinergic system (1982) (9)
- Reimbursement Status and Recommendations Related to Orphan Drugs in European Countries (2019) (9)
- Anxiolytic-like activity of MGS0039, a selective group II mGlu receptor antagonist, is serotonin- and GABA-dependent. (2011) (9)
- An interaction of histamine H2-receptor antagonists with the noradrenergic system in rat brain. (1978) (9)
- Influence of imipramine treatment on the group I of metabotropic glutamate receptors in CA1 region of hippocampus. (1997) (9)
- Depression and schizophrenia viewed from the perspective of amino acidergic neurotransmission: Antipodes of psychiatric disorders (2019) (8)
- N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline, an irreversible receptor inactivator, as a tool for measurement of alpha 2-adrenoceptor occupancy in vivo. (1992) (8)
- Chronic treatment with imipramine: Further functional evidence for the enhanced noradrenergic transmission in flexor reflex activity (1983) (8)
- The role of alpha 2-adrenoceptors in the mechanism of action of antidepressant drugs. (1987) (8)
- The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland (2016) (8)
- Histamine content and synthesis in central and pheripheral nerve structures during stress (1975) (8)
- The influence of mepyramine and burimamide on histamine induced catalepsy in the rat. (1975) (7)
- Application of magnetic resonance diffusion anisotropy imaging for the assessment neuroprotecting effects of MPEP, a selective mGluR5 antagonist, on the rat spinal cord injury in vivo. (2005) (7)
- Neurochemical changes underlying schizophrenia-related behavior in a modified forced swim test in mice (2018) (7)
- Cost‐Utility Analysis of Infliximab with Standard Care versus Standard Care Alone for Induction and Maintenance Treatment of Patients with Ulcerative Colitis in Poland (2016) (7)
- Disease activity, quality of life, and indirect costs of ulcerative colitis in Poland (2017) (7)
- Some central effects of impromidine, a potent agonist of histamine H2 receptors (1980) (7)
- Cost-Effectiveness Analysis of 1-Year Treatment with Golimumab/Standard Care and Standard Care Alone for Ulcerative Colitis in Poland (2016) (7)
- Developments in the discovery and design of intranasal antidepressants (2020) (6)
- Possible involvement of mGluR1 together with group II and III mGluRs in ibotenate-stimulated cAMP formation in the rat brain cortical slices. (2000) (6)
- Impact of Biologic Treatment of Crohn’s Disease on the Rate of Surgeries and Other Healthcare Resources: An Analysis of a Nationwide Database From Poland (2018) (6)
- Stimulation of group II metabotropic glutamate receptors or inhibition of group I ones exerts anxiolytic-like effects in rats (2000) (6)
- SupersensitiveΒ-adrenergic receptors are down-regulated in rat brain by mianserin administration (2005) (6)
- The enhancement and the inhibition of noradrenaune-induced cyclic amp accumulation in rat brain by stimulation of metabotropic glutamate receptors (1996) (6)
- Where do we go next in antidepressant drug discovery? A new generation of antidepressants: a pivotal role of AMPA receptor potentiation and mGlu2/3 receptor antagonism (2022) (6)
- Metabotropic Approaches to Anxiety (2010) (5)
- The enhancement and the inhibition of noradrenaline-induced cyclic AMP accumulation in rat brain by stimulation of metabotropic glutamate receptors. (1996) (5)
- Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland (2016) (5)
- Pretreatment with N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline accelerates the electroshock-induced decrease in density of β-adrenoceptors but not functional downregulation (1990) (5)
- Costs related to type 1 and 2 diabetes mellitus in Poland (2006) (5)
- Spaced electroconvulsive treatment: effects on responses associated with alpha 2- and 5-HT2-receptors. (1983) (4)
- The hyperthermic phase of histamine action in rats. (1980) (4)
- Developmental changes in the modulation of cyclic amp accumulation by activation of metabotropic glutamate receptors. (2001) (4)
- Reserpinization enhances electroconvulsive treatment effects on cortical α1-adrenoceptors (1988) (4)
- MPEP, mGlu5 receptor antagonist, regulates NPYmRNA expression in hippocampal and amygdalar neurons. (2004) (4)
- The influence of histamine liberator compound 48/80 on histamine level in sciatic nerve of the rat. (1974) (4)
- Intraamygdaloid administration of BIBO 3304 increases water intake and extends anxiolytic effects. (2004) (4)
- Synergistic interaction between alpha- and beta-adrenergic receptors in rat brain slices: possible site for antidepressant drug action. (1985) (4)
- A bright future of researching AMPA receptor agonists for depression treatment (2012) (4)
- Analiza kosztów leczenia powikłań cukrzycy poniesionych przez płatnika w Polsce w 2002 roku (2004) (3)
- The attenuation by chronic electroconvulsive treatment of hypothermia induced by histamine H2-receptor stimulants in rats. (1983) (3)
- Breast cancer surgery decreases serum brain-derived neurotrophic factor concentrations in middle aged women: relationship to the serum C-reactive protein concentration. (2019) (3)
- The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent (2013) (3)
- Zinc and mental health. (2011) (3)
- Some behavioral effects of histamine H1-, and H2-receptor agonists in rats. (1979) (3)
- Vedolizumab Compared with Certolizumab in the Therapy of Crohn Disease: A Systematic Review and Indirect Comparison (2016) (3)
- A cost-effectiveness analysis of treatment of diabetic complications in 2002 (2004) (3)
- Influence of chronic imipramine administration on the CaM-KII activity in postsynaptic densities and synaptosomal plasma membrane fraction isolated from the rat frontal cortex and hippocampus. (2000) (2)
- The action of histamine, histamine H1-and H2-receptor agonists on noradrenaline level in rat brain. (1979) (2)
- Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193). (1989) (2)
- Therapeutic drug monitoring of depression – Amplification by magnesium ions (2015) (2)
- Systemic Solutions, Legislative And Organizational Frameworks Aimed To Prevent Or Mitigate Drug Shortages In European Countries (2016) (2)
- Are pharmacological properties of anticoagulants reflected in pharmaceutical pricing and reimbursement policy? Out-patient treatment of venous thromboembolism and utilization of anticoagulants in Poland. (2014) (2)
- Inflammatory bowel diseases (IBD) as public health problem – review of the literature (2016) (2)
- Corrigendum to “Anxiolytic-like effects of MTEP, a potent and selective mGlu5 receptor antagonist does not involve GABAA signaling” [Neuropharmacology 47 (2004) 342–350] (2004) (2)
- The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT1A signalling (2013) (2)
- The histamine-induced skin reaction in schizophrenic and normal subjects. (1982) (2)
- Trans-(±)-1-amino-1, 3-cyclopentanedicarboxylate (trans-ACPD) stimulates cAMP accumulation in rat cerebral cortical slices but not in glial or neuronal cell cultures (1994) (2)
- A comparison of norepinephrine stimulated inositol phosphate accumulation in cerebral cortex of the Acomys cahirinus, the laboratory mice and the rat. (1988) (2)
- New 1,2,4-oxadiazole derivatives with positive mGlu4 receptor modulation activity and antipsychotic-like properties (2021) (1)
- The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies (2014) (1)
- The mechanism of antipsychotic-like action of the mGlu receptor activators: Focus on GABAergic signaling (2015) (1)
- Antidepressant-like activity of metabotropic glutamate receptors (2010) (1)
- APPLICATION OF CITICOLINE IN SUPPORTING THERAPY OF SELECTED DISEASES (2022) (1)
- Application of the MR Diffusion Anisotropy Imaging for the Assessment of MPEP Neuroprotection Effects on the Rat Spinal Cord Injury in vivo (2002) (1)
- Chronic co-treatment of NS398 (COX-2 inhibitor) with MTEP changes strategy of mice in Barnes Maze, through membrane resistance variation (2018) (1)
- Catalepsia-like symptoms produced by histidine in rats (1973) (1)
- Pharmaco-Electroencephalography-Based Assessment of Antidepressant Drug Efficacy—The Use of Magnesium Ions in the Treatment of Depression (2021) (1)
- Polski rynek farmaceutyczny a integracja Europejska (2003) (1)
- Metabotropic glutamate receptors (2007) (1)
- Role of Neurotoxicity in Depression (2014) (1)
- The functional cooperation of 5-HT1A and mGlu4R in HEK-293 cell line (2020) (1)
- P.2.c.018 Zinc supplementation enhances the therapeutic response in treatment resistant unipolar depression (2006) (1)
- [The role of the cytostatic drugs unit in rationalization of hospital drugs management--the case study and the analysis of drug utilization]. (2014) (1)
- Effects of acute mGluR7 PAM on changes in short-time plasticity and mGluR7 levels after chronic treatment with mGluR5 antagonist and COX-2 inhibitor (2018) (1)
- The influence of histamine H2-receptor antagonists on monoaminergic systems in rat brain (1979) (1)
- P.2.a.005 Chronic co-administration of mGluR5 antagonist (MTEP) with COX-2 inhibitor (NS398) affects DSCAM expression in prefrontal cortex and hippocampus in C57Bl/6J mice (2017) (1)
- [Zinc homeostasis and glutamatergic system in the pathogenesis and treatment of depression]. (2001) (1)
- Dependence of the lower limit of hydrogen explosivity on the initial temperature of the hydrogen mixture with air (1968) (0)
- P.2.a.003 NS-398 potentiates the antidepressant-like effect of MTEP in mice: involvement of pro-inflammatory cytokine pathways in the brain (2017) (0)
- P.1.009 Cell synchronisation as a tool to optimise expression of metabotropic glutamate receptors in inducible mammalian expression system (2013) (0)
- S.11.02 The possible role of mGluR4 in drug addiction (2016) (0)
- Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats (2016) (0)
- P.2.a.008 Pro-depressive-like effects of mGlu4 selective agonist LSP4–2022 in mice (2015) (0)
- CHANGES IN ALPHA2 - ADRENORECEPTOR DENSITY AFTER CHRONIC TREATMENT WITH IMIPRAMINE (1980) (0)
- [Not Available]. (2002) (0)
- A possible serotoninergic link in the hypothermic action of histamine (1979) (0)
- Synthesis and characterization of novel metabotropic glutamate receptor 2/3 (mGluR2/3) positive allosteric modulator (PAM) (2011) (0)
- The anxiolytic effect of CRF in rat brain frontal cortex is prevented by CRF1&2 receptor antagonists (2006) (0)
- CHL1 gene expression of human blod lymphocytes as SSRI response biomarker (2013) (0)
- Stimulation of group 11 metabotropic glutamate receptors counteracts parkinsonian-like muscle rigidity (1998) (0)
- Cell synchronization as a tool to optimize protein expression level of mGlu receptors in applying the inducible expression system (2012) (0)
- IP562083 a novel mGluR7 negative allosteric modulator (2015) (0)
- Behaviorai effects of repeated treatment with amitriptyline and citalopram in the olfactory buibectomy model of depression in C57BL/6J mice (2005) (0)
- Potential antidepressant-like effects of MPEP, a potent, selective and systemically active mGluR5 receptor antagonist (2001) (0)
- Modified swim test as a model of depressive-like negative symptoms of schizophrenia: GABAergic and serotonergic signaling (2015) (0)
- The involvement of GABAB signalling in the antipsychotic-like action of the novel orthosteric agonist of mGlu4receptor – LSP4 (2016) (0)
- P.1.h.011: AMN082, a positive allosteric modulator of the mGlu7 receptor, enhances the antidepressant-like activity of scopolamine in the tail suspension test (2017) (0)
- The Loss Od Glutamate-GABA Harmony in Anxiety Disorders: towards the Yin/Yang Based Brain Theory. (2011) (0)
- The enhancement of noradrenaline induced cyclic AMP accumulation in rat brain by stimulation of metabotropic glutamate receptors occurs in cerebral cortical slices and is mediated by endogenous adenosine (1995) (0)
- Effect of histamine H2-receptor antagonists on concentration of noradrenaline, dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid in rat brain. (1979) (0)
- The antipsychotic activity of mGlu receptor agents, focus on novel allosteric vs. orthosteric agonists of mGlu4 receptors (2016) (0)
- Reserpinization enhances electroconvulsive treatment effects on cortical alpha 1-adrenoceptors. (1988) (0)
- P.4.01 Effects of group II metabotropic glutamate receptor antagonist, MGS0039 in rodent tests of anxiety-like behaviour (2009) (0)
- Metabotropic glutamate receptor ligands as a possible targets for treatment of anxiety and depression (2009) (0)
- P.2.12 Interaction between metabotropic glutamate 5 receptors and NPY in the amygdala as a novel mechanism of anxiolysis (2004) (0)
- Identification and characterization of new 5-HT7 receptor inverse agonists (2012) (0)
- Anxiolytic-like effects of group III mGluR positive modulator PHCCC and agonist ACPT-I injected to the rat hippocampus (2006) (0)
- The inhibition and enhancement by excitatory amino acids of noradrenaline-stimulated cyclic AMP accumulation in rat cerebral cortical slices (1995) (0)
- The quest for allosteric binding sites in mGluRs group III (2012) (0)
- The influence of tryptophan-deficient diet on liver cytochrome P450 (2012) (0)
- B12 METABOTROPIC GLUTAMATE RECEPTORS AS POTENTIAL TARGETS OF ANTIPARKINSONIAN THERAPY (2005) (0)
- [Clinical efficacy and safety of prolonged use of the valganciclovir for the treatment of cytomegalovirus disease in patients after kidney transplantation]. (2013) (0)
- CHANGES IN STRIATAL AND MESOLIMBIC DOPAMINE RECEPTORS AFTER SINGLE IN VIVO ADMINISTRATION OF MORPHINE (1980) (0)
- Effect of histidine on the formation of catalepsia-like symptoms in rats. (1973) (0)
- The influence of magnesium on the action of the anti-depressant drugs in swim test in mice (2005) (0)
- Expression of metabotropic glutamate receptors in mammalian cells as a method for identification of new chemical compounds with drug-like activity (2013) (0)
- The role of GABAergic transmission in the behavioral effects of mGlu7 receptor positive modulator, AMN082 (2009) (0)
- Potential anxiolytic- and antidepressant-like activity of Dipraglurant (ADX48621), the novel negative allosteric modulator (NAM) of the metabotropic glutamate 5 (mGlu5) receptor (2015) (0)
- The influence of LY354740 - an agonist of group-II metabotropic glutamate receptors (mGLuR II) on neuronal apoptosis in primary neurons (2011) (0)
- The most frequently cited Polish pharmacologists, physiologists and pathophysiologists (2015) (0)
- P.3.c.011 The antipsychotic-like activity of VU152100, a muscarinic M4 receptor positive allosteric modulator, in animal models of schizophrenia (2016) (0)
- Wieronska-BehvBrRes-2013-298 (2013) (0)
- Potential anti-anxiety effects of gropu II glutamate metabotropic receptor agonists in animal models (1999) (0)
- Mutual activation of glutamatergic mGlu4 and muscarinic M4 receptors reverses schizophrenia-related changes in rodents (2018) (0)
- P.2.h.004 Antidepressant and antipsychotic-like effects of GABA-B receptor ligands in mGlu7 deficient mice (2010) (0)
- THE DIFFERENTIAL EFFECTS OF EXCITATORY AMINO ACIDS ON CYCLIC AMP ACCUMULATION IN RATS, THE INFLUENCE OF PROLONGED ANTIDEPRESSANT TREATMENT (1992) (0)
- On the role of group I metabotropic glutamate receptors in the mechanism of action of antidepressant drugs (2001) (0)
- Involvement of protein kinase a in the mechanism of antidepressant action (1999) (0)
- P.1.009 Co-administration of COX-2 inhibitor NS-398 enhances antidepressant effect of mGluR5 antagonist MTEP in mice (2017) (0)
- Metabotropic glutamate receptors counteract muscle rigidity induced by haloperidol (1999) (0)
- P.1.g.033 Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of scopolamine in behavioural models of depression (2016) (0)
- 106-5 Antidepressant treatment influences metabotropic receptors for excitatory amino acids in rat brain (1997) (0)
- Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu7 Receptor Modulation Activity and Antipsychotic-Like Properties (2023) (0)
- P.3.e.005 The involvement of GABAB receptors in antipsychotic-like effects of positive allosteric modulator of muscarinic acetylcholine M4 receptors (2017) (0)
- Anxiolytic-like action of LY487379 after central administration in rats (2011) (0)
- The effect of chronic treatment with imipramine, ECS and nifedipine on the beta-adrenergic function in the rat hippocampal slices. (1993) (0)
- Influence of mGluR7 gene knockout and behavioral changes which its causes on male mice fertility (2012) (0)
- An influence of compounds acting on glutamatergic and noradrenergic receptors on the tremor induced by harmaline; automatic measurements by force plate actimeters (2013) (0)
- Anxiolytic-like effects of CGP 36742 an antagonist of GABAB receptors in animal models (2001) (0)
- The influence of antidepressant treatments on protein kineses activity in rat brain (1997) (0)
- BEHAVIORAL AND BIOCHEMICAL STUDIES ON AZIDOMORPHINES. II. ACTION ON OPIATE AND CATECHOLAMINE RECEPTORS (1980) (0)
- Sensitivity to paroxetine-induced inhibition of lymphocyte growth in depressed patients as state marker of depression (2015) (0)
- Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes (1982) (0)
- Effects of South Africa traditional medicine in animal models of depression (2008) (0)
- Metabotropic glutamate receptors PAMs as a novel, potential antipsychotic drugs (2013) (0)
- Abstract WP425: Blood Brain Barrier Disruption and Vascular Cognitive Impairment in Early Stages of Heart Failure Development in Tgαq*44 Mice (2016) (0)
- Characterization of compound C46: a novel positive allosteric modulator? (2011) (0)
- The antagonists of metabotropic glutamate receptors produce anxiolytic-like effects and attenuate morphine abstinence symptoms in animals (1996) (0)
- IF270750: Synthesis and pharmacology of novel mGluR4 positive allosteric modulator (2012) (0)
- S.28.04 The antidepressant potential of mGluR5 and GABA-B receptor antagonists in rodent models of depression (2010) (0)
- Metabotropic glutamate receptors as targets for psychotropic drugs (2013) (0)
- The effect of interaction between (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid (1S,3R)-ACPD and noradrenaline on cyclic AMP accumulation: different actions in brain slices, primary glial and neuronal cell cultures. (1995) (0)
- The Transparency Of Published Recommendations On Reimbursement Of Health Technologies In Poland (2016) (0)
- P.2.g.008 Serum zinc level as potential marker in recurrent depressive disorder (2006) (0)
- Validation of HEK-293 cell line as a molecular tool for pharmacological study of mGluR7 receptor (2011) (0)
- Changes in group I metabotropic glutamate receptors immunoreactivity in rat hippocampus after electroconvulsive shock (2001) (0)
- Point mutation as a strategy for development a new tool in pharmacological research for mGluR7 allosteric modulators (2012) (0)
- Potential anti-addictive effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist (2002) (0)
- Adjustment of adenylate cyclase [EC 4.6.1.1] activity in HEK293 cells transiently expressing mGluRs group III (2011) (0)
- NS398 (COX-2 INHIBITOR) potentiates the antidepressant-like effects of MTEP (MGLUR5 ANTAGONIST): Involvement of 5-HT system (2017) (0)
- The evaluation of the role of mGluR7 in neuronal apoptotic processes by usage of AMN082, a selective mGluR7 agonist and mGluR7 knockout-derived cells (2013) (0)
- On the mechanism of antidepressant-like activity of mGlu5 allosteric modulators (2013) (0)
- On the mechanisms of anxiolytic-like effects of mGlu2/3 receptor agonist LY 379268 and positive modulator LY487379 in stress-induced hyperthermia model in mice (2011) (0)
- Searching for a new mGluRs positive allosteric modulators (2013) (0)
- mGlu4-dependent reversal of the MK-801-induced cognitive impartment involves 5-HT1A receptors (2012) (0)
- P.2.015 An anxiolytic but not antidepressant-like activity of a novel positive modulator of mGlu4 receptor Lu AF21394 (2012) (0)
- P.2.25 Anxiolytic-like effects of LY487379 an allosteric modulator of mGlu2 receptors in rats (2009) (0)
- Chronic effects of imipramine and nifedipine on the beta-adrenergic function in neuronal and glial primary cultures. (1993) (0)
- Characterization of metabotropic receptors for excitatory amino acids which stimulate cyclic AMP accumulation in rat brain (1997) (0)
- S.24.04 Inhibitory actions of mGlu4 receptor ligands on cocaine- but not nicotine-induced locomotor responses in rats (2012) (0)
- Agonists of mGluRs II/III attenuate the staurosporine-induced toxicity in human neuroblastoma SH-SY5Y cells (2011) (0)
- Mechanizmy przetwarzania sygnalu blonowego przy udziale kinaz bialkowych zaleznych od cyklicznych nukleotydow (1997) (0)
- Biological drugs in the treatment of ankylosing spondylitis (AS) – systematic review (2016) (0)
- Refundacja w wybranych krajach Europy Środkowowschodniej (2004) (0)
- "Józef Chlebowczyk - badacz procesów narodotwórczych w Europie XIX i XX wieku", ed. Maria W. Wanatowicz, Katowice 2007 : [recenzja] / Andrzej Pilc. (2010) (0)
- Indirect costs of diabetes mellitus in Poland (2006) (0)
- Antibiotic consumption and antimicrobial resistance in Poland; findings and implications (2018) (0)
- Cost-utility analysis of 1-year treatment with adalimumab/standard care and standard care alone for ulcerative colitis in Poland (2016) (0)
- Interakcje układu glutaminianergicznego z cynkiem (2002) (0)
- Neurotoxicity in Depression (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Andrzej Pilc?
Andrzej Pilc is affiliated with the following schools:
